YPL034W Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YPL034W antibody; Uncharacterized protein YPL034W antibody
Target Names
YPL034W
Uniprot No.

Q&A

What is YPL034W and why are antibodies against it important for research?

YPL034W is a gene designation in the yeast Saccharomyces cerevisiae. Antibodies against the protein encoded by this gene are valuable research tools for studying its expression, localization, and function within cellular contexts. These antibodies enable detection and quantification of the protein in various experimental setups, allowing researchers to understand its role in biological processes. In particular, YPL034W may be involved in cellular responses to oxidative stress, as research has demonstrated complex genetic and molecular mechanisms underlying oxidative stress tolerance in yeast . Antibodies targeting this protein can help elucidate its specific function in these pathways through techniques such as western blotting, immunoprecipitation, and chromatin immunoprecipitation (ChIP).

How do I validate the specificity of a YPL034W antibody?

Validating antibody specificity is crucial for ensuring reliable experimental results. For YPL034W antibodies, consider the following methodological approach:

  • Genetic validation: Test the antibody in wild-type versus YPL034W deletion strains. A specific antibody should show no signal in the deletion strain.

  • Western blot analysis: Verify that the antibody detects a band of the expected molecular weight. Include appropriate positive and negative controls.

  • Epitope competition assay: Pre-incubate the antibody with purified YPL034W protein or peptide before immunodetection. A specific antibody will show reduced or absent signal.

  • Cross-reactivity testing: Test the antibody against closely related proteins to ensure it doesn't detect off-target proteins.

  • Immunoprecipitation followed by mass spectrometry: This approach can confirm that the antibody is pulling down the intended target.

These validation steps are essential before using the antibody in more complex experimental designs such as ChIP analysis, which has been employed to study related proteins in yeast .

What are the optimal fixation and permeabilization conditions for immunofluorescence using YPL034W antibodies?

When performing immunofluorescence with YPL034W antibodies in yeast cells, consider these methodological details:

  • Fixation: 4% formaldehyde for 15-30 minutes at room temperature is typically effective for yeast cells. For studying nuclear proteins, this preserves nuclear architecture while maintaining antigen accessibility.

  • Permeabilization: After fixation, treat with a mixture of 0.1% Triton X-100 in PBS for 5-10 minutes. For difficult-to-access nuclear antigens, consider additional enzymatic digestion of the cell wall using zymolyase (1 mg/ml for 20 minutes).

  • Blocking: Use 3-5% BSA or 5-10% normal serum in PBS with 0.1% Tween-20 for 30-60 minutes to reduce background.

  • Antibody incubation: Dilute primary antibody (typically 1:100 to 1:500) in blocking solution and incubate overnight at 4°C for optimal binding.

  • Controls: Always include a negative control (no primary antibody) and, if possible, a YPL034W deletion strain to confirm specificity.

The exact conditions may require optimization based on the specific antibody and the fixation-sensitive nature of the epitope being targeted.

How can I optimize ChIP protocols specifically for YPL034W antibodies in stress-response studies?

Chromatin immunoprecipitation (ChIP) with YPL034W antibodies requires careful optimization, particularly when studying stress responses:

Stress ConditionRecommended Crosslinking TimeOptimal Antibody AmountKey Control Regions
Normal growth10 minutes2-3 μgACT1, RPS16B
Oxidative stress8 minutes3-4 μgTSA1/2, GAL1
Heat shock7 minutes4-5 μgHSP genes

How do I address epitope masking issues when using YPL034W antibodies under oxidative stress conditions?

Epitope masking is a significant challenge when studying proteins under oxidative stress conditions, as protein modifications and conformational changes can affect antibody binding. For YPL034W antibodies, consider this methodological approach:

  • Use multiple antibodies: Employ antibodies targeting different epitopes of YPL034W to cross-validate results. This strategy helps identify if masking is epitope-specific.

  • Denaturing conditions: For some applications (like western blotting), stronger denaturing conditions can expose masked epitopes. Test increasing SDS concentrations or heat treatment.

  • Protein modification analysis: Consider that oxidative stress induces post-translational modifications. Perform immunoprecipitation followed by mass spectrometry to identify modifications that might interfere with antibody binding.

  • Native vs. denatured detection: Compare results from native conditions (like co-IP) with denaturing methods (like western blotting) to identify potential conformation-dependent masking.

  • Reducing agents: Test the effects of different reducing agents (DTT, β-mercaptoethanol) and concentrations, as they can affect epitope accessibility under oxidative conditions.

Research has shown that oxidative stress response involves complex genetic mechanisms with transcriptional changes in stress-responsive genes . These transcriptional changes likely correspond to protein-level changes that may affect antibody-epitope interactions.

What are the optimal approaches for multiplexing YPL034W antibodies with other stress-response markers?

When designing multiplexed immunodetection experiments with YPL034W antibodies:

  • Antibody compatibility: Ensure antibodies are raised in different host species to allow simultaneous detection. For example, use rabbit anti-YPL034W with mouse anti-Tsa1/2 (oxidative stress markers).

  • Fluorophore selection: Choose fluorophores with minimal spectral overlap. For three-color imaging, consider combinations like Alexa 488, Cy3, and Cy5.

  • Sequential immunodetection: If antibodies are from the same species, use sequential immunodetection with a complete blocking step between rounds.

  • Cross-reactivity testing: Pre-test all antibodies in the multiplex panel individually to ensure no cross-reactivity occurs.

  • Quantitative colocalization: Use appropriate software (ImageJ with Coloc2, CellProfiler) to quantify colocalization between YPL034W and other markers.

For oxidative stress studies specifically, consider these marker combinations:

Primary MarkersSecondary MarkersApplication
YPL034W + Tsa1/2Yap1 (transcription factor)Oxidative stress response pathway analysis
YPL034W + H2O2-specific damage markersMitochondrial markersCompartment-specific damage assessment
YPL034W + RNA Pol IIChromatin markersTranscriptional regulation under stress

The combination of these markers can provide insights into how YPL034W functions within the broader context of cellular stress responses, particularly oxidative stress tolerance mechanisms described in the literature .

How can I design experiments to determine if YPL034W is involved in the oxidative stress response pathway?

To investigate YPL034W's potential role in oxidative stress response:

  • Genetic approach: Generate YPL034W deletion and overexpression strains. Compare their growth and survival under various oxidative stressors (H₂O₂, paraquat, menadione) at different concentrations and exposure times.

  • Localization studies: Use immunofluorescence with YPL034W antibodies to track protein localization before and after oxidative stress. Changes in localization can indicate functional involvement in stress response.

  • ChIP-seq analysis: If YPL034W is potentially a transcription factor or chromatin-associated protein, perform ChIP-seq before and after oxidative stress treatment to identify binding sites and potential target genes.

  • Protein interaction studies: Use co-immunoprecipitation with YPL034W antibodies followed by mass spectrometry to identify stress-dependent protein interactions.

  • Gene expression analysis: Compare transcriptional profiles of wild-type versus YPL034W mutant strains under oxidative stress to identify affected pathways.

This experimental approach mirrors successful strategies used to study other genes involved in oxidative stress tolerance, where researchers identified that specific gene duplications (such as Chromosome IV disomy affecting TSA2) can buffer oxidative stress-responsive gene expression . Similar mechanisms might involve YPL034W.

What are the best approaches for resolving contradictory results when using different YPL034W antibody clones?

When faced with contradictory results from different antibody clones:

  • Epitope mapping: Determine the exact epitopes recognized by each antibody clone. Differences in epitope location can explain discrepancies, especially if post-translational modifications or protein interactions mask specific regions.

  • Validation hierarchy: Establish a validation hierarchy for your antibodies:

    • Genetic validation (testing in knockout strains)

    • Western blot with recombinant protein

    • Mass spectrometry confirmation of immunoprecipitated proteins

    • Functional assays

  • Condition-specific performance: Test each antibody under various experimental conditions. Some antibodies may perform well in fixed samples but poorly in native conditions, or vice versa.

  • Cross-validation with orthogonal methods: Confirm key findings using non-antibody-based methods such as:

    • CRISPR-tagging of endogenous YPL034W with fluorescent proteins

    • RNA-based detection methods

    • Activity-based protein profiling

  • Statistical approach: Quantify results from multiple antibodies and consider the consensus result, reporting the variability as part of your findings.

This systematic approach helps distinguish between genuine biological phenomena and antibody-specific artifacts, particularly important when studying stress responses where protein states can change dramatically.

How do I integrate YPL034W antibody-based findings with computational predictions of antibody-antigen interactions?

Modern research increasingly combines experimental antibody-based data with computational predictions:

  • Structural prediction validation: Use experimental binding data from your YPL034W antibodies to validate and refine computational models like AntiBinder, which employs bidirectional cross-attention mechanisms to learn intrinsic antigen-antibody binding patterns .

  • Epitope mapping integration: Compare computationally predicted epitopes with experimentally determined epitopes from your YPL034W antibodies. Areas of agreement strengthen both approaches; discrepancies highlight areas for further investigation.

  • Cross-species prediction testing: If working with antibodies that recognize YPL034W homologs in other species, use your experimental data to test the cross-species prediction capabilities of computational models, a challenge area noted in computational approaches like AntiBinder .

  • Prediction-guided antibody design: Use computational predictions to design new antibodies targeting specific epitopes of YPL034W that might be functionally relevant in stress responses.

  • Combined scoring systems: Develop integrated scoring systems that incorporate both experimental binding affinities and computational prediction scores for a more robust analysis.

Computational models like AntiBinder have demonstrated the ability to predict complex antibody-antigen interactions without manual feature engineering , making them valuable complements to experimental approaches with YPL034W antibodies.

How can I address non-specific binding issues with YPL034W antibodies in whole-cell extracts?

Non-specific binding is a common challenge with antibodies in complex samples:

  • Blocking optimization: Test different blocking agents (BSA, milk, normal serum, commercial blockers) at various concentrations (3-10%) and times (1-3 hours). For yeast samples, a combination of 5% milk with 1% BSA often reduces background effectively.

  • Sample preparation refinement: For yeast extracts specifically:

    • Use spheroplasting methods that preserve protein integrity

    • Include protease inhibitors and phosphatase inhibitors if studying phosphorylated forms

    • Test different lysis methods (mechanical, detergent-based, enzymatic) to find the optimal approach for YPL034W detection

  • Antibody dilution series: Create a dilution series (typically 1:250 to 1:5000) to identify the optimal antibody concentration that maximizes specific signal while minimizing background.

  • Pre-adsorption protocol: Pre-adsorb your antibody with extracts from YPL034W deletion strains to remove antibodies that bind to other yeast proteins.

  • Detergent screening: Test the addition of various detergents (Tween-20, Triton X-100, NP-40) at low concentrations (0.05-0.1%) to reduce non-specific hydrophobic interactions.

These optimization strategies can significantly improve signal-to-noise ratios when working with YPL034W antibodies in complex yeast extracts, particularly in challenging contexts like stress response studies.

What are the critical considerations when using YPL034W antibodies for analyzing protein-chromatin interactions?

When studying YPL034W protein-chromatin interactions:

  • Crosslinking optimization: Different crosslinkers have varying effects on chromatin structure and protein-DNA interactions:

    • Formaldehyde (1%) is standard but may not capture all interactions

    • Dual crosslinking with DSG or EGS followed by formaldehyde can capture protein-protein interactions before protein-DNA fixation

    • Shorter crosslinking times (5-10 minutes) may better preserve transient interactions

  • Sonication parameters: Optimizing chromatin fragmentation is crucial:

    • For yeast, aim for 200-500bp fragments

    • Test different sonication cycles and powers

    • Verify fragmentation by gel electrophoresis before proceeding

  • Antibody validation for ChIP: Not all antibodies that work for western blotting work for ChIP:

    • Test multiple antibody concentrations (2-10 μg per ChIP)

    • Include appropriate controls (IgG, input, YPL034W deletion)

    • Verify enrichment at known binding sites if available

  • Sequential ChIP considerations: For co-occupancy studies with other factors:

    • Ensure complete elution between rounds

    • Test antibody compatibility with elution conditions

    • Consider native ChIP for certain applications

  • Data normalization approaches: Proper normalization is essential:

    • Use spike-in controls for quantitative comparisons

    • Normalize to appropriate reference genes

    • Consider using the same starting cell numbers across conditions

Research has demonstrated successful ChIP analysis of chromatin-associated factors in yeast using similar methodological approaches , which can be adapted for studying YPL034W.

How do I optimize immunoprecipitation protocols to capture transient YPL034W interactions during stress responses?

Capturing transient protein interactions during stress responses requires specialized approaches:

  • In situ crosslinking: Crosslink cells directly in culture media immediately after stress treatment:

    • Use membrane-permeable crosslinkers like DSP or formaldehyde

    • Optimize crosslinking times (typically shorter for stress responses - 5-8 minutes)

    • Consider reversible crosslinkers if downstream applications require native protein

  • Rapid sample processing: Minimize the time between stress application and protein extraction:

    • Use rapid lysis methods (e.g., cryogenic grinding)

    • Maintain stress conditions during early processing steps when possible

    • Include phosphatase inhibitors to preserve stress-induced modifications

  • Buffer optimization: Test different IP buffers varying in:

    • Salt concentration (150-500 mM NaCl)

    • Detergent type and concentration

    • pH (especially important for nuclear proteins)

  • Antibody coupling strategies: Consider covalently coupling YPL034W antibodies to beads:

    • Reduces antibody contamination in eluates

    • Allows for more stringent washing

    • Enables native elution of complexes

  • Two-step IP approaches: For detecting weak or transient interactions:

    • Tandem affinity purification with tagged YPL034W and antibody-based detection

    • BioID or APEX proximity labeling followed by YPL034W antibody validation

    • Combination of chemical crosslinking with immunoprecipitation

These approaches can help capture the dynamic protein interaction networks involving YPL034W during oxidative stress responses, providing insights into its functional role in stress tolerance mechanisms .

How might advanced antibody engineering improve YPL034W detection in complex stress response studies?

Emerging antibody technologies offer new possibilities for YPL034W research:

  • Single-domain antibodies (nanobodies): These smaller antibody fragments derived from camelid antibodies offer several advantages:

    • Better penetration into condensed chromatin structures

    • Recognition of epitopes inaccessible to conventional antibodies

    • Reduced background in imaging applications

    • Potential for intracellular expression as "intrabodies"

  • Conformation-specific antibodies: Developing antibodies that specifically recognize stress-induced conformational changes in YPL034W could:

    • Allow direct detection of activated/inactive states

    • Enable monitoring of protein dynamics during stress response

    • Provide insights into protein function that traditional antibodies miss

  • Multiplexed epitope detection: Creating panels of YPL034W antibodies that:

    • Target different regions of the protein

    • Work in combination to provide structural information

    • Allow simultaneous detection of multiple protein states

  • Recombinant antibody engineering: Custom-designed recombinant antibodies could:

    • Incorporate site-specific conjugation for precise labeling

    • Feature enhanced stability under stress-mimicking conditions

    • Offer increased specificity through affinity maturation

  • Bispecific antibodies: These engineered antibodies could:

    • Simultaneously bind YPL034W and known interaction partners

    • Enable direct detection of protein complexes

    • Facilitate pull-down of specific subcomplexes

These advanced antibody technologies could significantly enhance our ability to study YPL034W's role in complex cellular processes like oxidative stress response, where traditional approaches might miss critical but transient interactions or conformational changes.

What are the promising approaches for correlating YPL034W antibody-based findings with functional genomics data?

Integrating antibody-based protein data with genomic approaches:

  • ChIP-seq and RNA-seq integration: Correlate YPL034W binding sites (from ChIP-seq) with gene expression changes (from RNA-seq):

    • Map YPL034W occupancy under normal and stress conditions

    • Identify direct transcriptional targets

    • Correlate binding strength with expression changes

  • Proteogenomic analysis: Combine antibody-based proteomics with genetic screens:

    • Use YPL034W antibodies for protein quantification across genetic backgrounds

    • Correlate protein levels with genetic interaction profiles

    • Identify conditions where protein levels don't match transcript levels

  • Single-cell approaches: Combine single-cell genomics with antibody-based detection:

    • Correlate YPL034W protein levels with transcriptional heterogeneity

    • Identify cell-state-dependent functions

    • Map protein localization to transcriptional states

  • Spatial transcriptomics integration: Correlate spatial distribution of YPL034W (from imaging) with local transcriptional environments:

    • Map protein localization to specific genomic regions

    • Identify spatial organization of stress response elements

    • Connect nuclear positioning with gene expression changes

  • Genetic engineering validation: Use targeted genetic modifications to test hypotheses:

    • CRISPR-based mutagenesis of predicted binding sites

    • Promoter modifications to alter expression dynamics

    • Domain swaps to test structural predictions

These integrated approaches can provide a more comprehensive understanding of YPL034W's role in complex cellular processes like oxidative stress response, where genomic and proteomic changes must be coordinated .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.